Informed-money record

KROS · Keros Therapeutics, Inc.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

3

Bearish filings

25

Named actors

18

Disclosed $ (bull / bear)

$45K / $183.0M

Recent disclosures

25 of 28 in the window · linked to source
DateWhoWhatDisclosed $Receipt
2026-06-11Director (via UBS Financial Services, Inc.) Newton Charles W.filed notice to sell$5KSEC ↗
2026-06-04Director Seth Alpnasold$28KSEC ↗
2026-06-04Director Farzan Nimasold$28KSEC ↗
2026-06-04Director Knowles Juliussold$28KSEC ↗
2026-06-04Director (via UBS Financial Services, Inc.) Seth Alpnafiled notice to sell$28KSEC ↗
2026-06-04Director (via UBS Financial Services, Inc.) Knowles Juliusfiled notice to sell$28KSEC ↗
2026-06-04Director (via UBS Financial Services, Inc.) Farzan Nimafiled notice to sell$28KSEC ↗
2026-05-15Director BIENAIME JEAN JACQUESbought$11KSEC ↗
2026-05-14member of our board of directors Charles Newtonadopted a selling planSEC ↗
2026-04-15Director BIENAIME JEAN JACQUESbought$12KSEC ↗
2026-03-31Shareholder (via Themis Trading LLC) OrbiMed Genesis Master Fund, LPfiled notice to sell$497KSEC ↗
2026-03-09Director BIENAIME JEAN JACQUESbought$22KSEC ↗
2026-03-04member of our board of directors Nima Farzanadopted a selling planSEC ↗
2026-03-04Chief Financial Officer Keith Regnanteadopted a selling planSEC ↗
2026-03-04Chief Scientific Officer Lorena Lerneradopted a selling planSEC ↗
2026-03-04Julius Knowlesadopted a selling planSEC ↗
2026-02-19CHIEF EXECUTIVE OFFICER Seehra Jasbirsold$113KSEC ↗
2026-02-18CHIEF FINANCIAL OFFICER Regnante Keithsold$77KSEC ↗
2026-02-18Chief Science Officer Lerner Lorena Raquelsold$63KSEC ↗
2026-02-18SVP, General Counsel Cho Esthersold$78KSEC ↗
2025-10-1510% owner / other Schneeberger Danielsold$13.2MSEC ↗
2025-10-1510% owner / other Schneeberger Danielsold$77.9MSEC ↗
2025-10-1510% owner / other Schneeberger Danielsold$4.5MSEC ↗
2025-10-1510% owner / other Pontifax (China) IV L.P.sold$2.8MSEC ↗
2025-10-1510% owner / other Pontifax (China) IV L.P.sold$40.6MSEC ↗

3 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →
Dispute or correct this record

This page is a dated factual record built from public filings, each row linked to its source. If a row is wrong — a misattributed filing, a wrong name, a record that should not merge — tell us what and why.

Reviewed by a human; the page never changes automatically.

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals